Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 30 Issue 2
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2012  >  30(2): 143-145

CHENG Long, LIU Bing-lin, LV Jia-kang. Regulation changes in the clinical efficacy evaluation of Traditional Chinese[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 143-145. doi: 10.3969/j.issn.1006-0111.2012.02.017
Citation: CHENG Long, LIU Bing-lin, LV Jia-kang. Regulation changes in the clinical efficacy evaluation of Traditional Chinese[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 143-145. doi: 10.3969/j.issn.1006-0111.2012.02.017
shu

Regulation changes in the clinical efficacy evaluation of Traditional Chinese

doi: 10.3969/j.issn.1006-0111.2012.02.017

  • Center for Drug Evaluation State Food and Drug administration, Beijing 100038, China

  • Received Date: 2012-02-23
  • Rev Recd Date: 2012-03-12
  • The original and current regulations were reviewed. Three key points of regulation changes in efficacy evaluation were summarized, such as indications for the syndromes of Traditional Chinese Medicine, Traditional Chinese medicine for the disease and syndrome, and the requirements of control group. The related articles were interpretation, the challenges and counter-measurements were built up.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2276) PDF downloads(638) Cited by()

Related
Proportional views

Regulation changes in the clinical efficacy evaluation of Traditional Chinese

doi: 10.3969/j.issn.1006-0111.2012.02.017
  • Center for Drug Evaluation State Food and Drug administration, Beijing 100038, China
  • Received Date: 2012-02-23
  • Rev Recd Date: 2012-03-12

Abstract: The original and current regulations were reviewed. Three key points of regulation changes in efficacy evaluation were summarized, such as indications for the syndromes of Traditional Chinese Medicine, Traditional Chinese medicine for the disease and syndrome, and the requirements of control group. The related articles were interpretation, the challenges and counter-measurements were built up.

CHENG Long, LIU Bing-lin, LV Jia-kang. Regulation changes in the clinical efficacy evaluation of Traditional Chinese[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 143-145. doi: 10.3969/j.issn.1006-0111.2012.02.017
Citation: CHENG Long, LIU Bing-lin, LV Jia-kang. Regulation changes in the clinical efficacy evaluation of Traditional Chinese[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(2): 143-145. doi: 10.3969/j.issn.1006-0111.2012.02.017
shu

    HTML

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return